Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing

13Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hemophagocytic lymphohistiocytosis (HLH) composes a group of rare heterogenous disorders characterized by uncontrolled accumulation and infiltration of activated T lymphocytes and macrophages. Cytotoxic T and natural killer cell activity is significantly reduced or absent in these patients. Mutations in the important mediator of lymphocyte cytotoxicity perforin were identified in a number of HLH individuals. Here we report a novel missense mutation thr435met in the conserved Ca2+ binding domain of perforin in a patient with HLH. Prediction of the 3-dimensional structure of the thr435met perforin mutant using comparative molecular modeling indicates that the protein's ability to bind Ca2+, and therefore its cytolytic function, would be strongly compromised. In addition, this patient exhibited abnormal CD45 splicing caused by a C77G mutation in the gene encoding CD45 (PTPRC). Our findings suggest a combined role for perforin mutation and abnormal CD45 splicing as significant contributory factors in the pathogenesis of HLH. © 2003 Wiley-Liss, Inc.

Author supplied keywords

Cite

CITATION STYLE

APA

McCormick, J., Flower, D. R., Strobel, S., Wallace, D. L., Beverley, P. C. L., & Tchilian, E. Z. (2003). Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing. American Journal of Medical Genetics, 117 A(3), 255–260. https://doi.org/10.1002/ajmg.a.10010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free